PT-141 is a selective melanocortin-4 receptor agonist derived from Melanotan-II research. Review of preclinical evidence on MC4R mechanisms, central nervous system pathways, and reproductive research.
Lab Science
Understanding analytical testing, purity standards, and lab methods
AOD9604: The GH Fragment Built for Fat Metabolism Research
AOD9604 is a synthetic fragment of human growth hormone (amino acids 177-191) studied for selective lipolytic activity without growth-promoting effects. Review of preclinical research on mechanisms and metabolic findings.
What Is HPLC Testing? Peptide Purity Analysis Explained
HPLC is the gold standard for peptide purity analysis. Learn how it works, what the numbers mean, and why independent HPLC testing matters for research reliability.
NAD+ in Aging Research: Why Everyone Is Talking About It
NAD+ is a coenzyme central to cellular metabolism, DNA repair, and aging. This review covers the biochemistry, age-related decline, and key preclinical findings from published research.
Epithalon Peptide Research Overview
Epithalon is a synthetic tetrapeptide studied for its effects on telomerase activity, telomere elongation, and aging biomarkers. Review of the peer-reviewed literature from three decades of investigation.
Ipamorelin: The Cleanest Growth Hormone Secretagogue
Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without affecting cortisol, prolactin, or ACTH. Review of preclinical research on mechanisms, selectivity, and applications.
TB-500: Everything Researchers Need to Know
TB-500 is a synthetic analog of thymosin beta-4. This research review covers its molecular mechanisms, preclinical evidence in wound healing, cardiac research, and connective tissue models.
What Is Bacteriostatic Water? (And Why Regular Water Ruins Peptides)
Bacteriostatic water is sterile water preserved with 0.9% benzyl alcohol. Learn what it is, how it works, and why it matters for peptide reconstitution and research integrity.
The BPC-157 Debate: Miracle Peptide or Overhyped?
An evidence-based look at BPC-157 research including the 2025 systematic review, FDA Category 2 classification, WADA ban, and the gap between preclinical findings and human clinical data.
BPC-157 Administration Routes: Which One Works Best?
A research review of BPC-157 bioavailability across administration routes, pharmacokinetic data, and safety considerations based on published preclinical literature.